Acutaas Chemicals Intrinsic Value
Acutaas Chemicals (ACUTAAS) median intrinsic value is ₹994.36 from 9 valuation models (range ₹807–₹2092), vs current price ₹3268.60 — -69.6% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Acutaas Chemicals share price screener.
ACUTAAS Valuation Methods Summary — DCF, Graham Number & P/E
Acutaas Chemicals intrinsic value across 9 models vs current price ₹3268.60 — upside/downside and value range per method. Also explore ACUTAAS price trends to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1415.92 | ₹1132.74 - ₹1699.10 | -56.7% | EPS: ₹64.36, Sector P/E: 22x |
| Book Value Method | asset | ₹806.83 | ₹726.15 - ₹887.51 | -75.3% | Book Value/Share: ₹403.41, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹980.58 | ₹882.52 - ₹1078.64 | -70.0% | Revenue/Share: ₹433.17, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1902.44 | ₹1712.20 - ₹2092.68 | -41.8% | EBITDA: ₹780.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1307.44 | ₹1045.95 - ₹1568.93 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹980.58 | ₹882.52 - ₹1078.64 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹994.36 | ₹894.92 - ₹1093.80 | -69.6% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹2091.71 | ₹1882.54 - ₹2300.88 | -36.0% | ROE: 32.4%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹980.58 | ₹882.52 - ₹1078.64 | -70.0% | EPS: ₹64.36, BVPS: ₹403.41 |
ACUTAAS Intrinsic Value vs Market Price — All Valuation Models
Acutaas Chemicals fair value range ₹807–₹2092 vs current market price ₹3268.60 across 9 valuation models. Browse ACUTAAS balance sheet details for revenue, profit, balance sheet and cash flow data.
ACUTAAS Intrinsic Value Analysis — Undervalued or Overvalued?
Acutaas Chemicals median intrinsic value ₹994.36, current price ₹3268.60 — Trading Above Calculated Value by 69.6%, margin of safety -100.0%.
What is the intrinsic value of ACUTAAS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Acutaas Chemicals (ACUTAAS) is ₹994.36 (median value). With the current market price of ₹3268.60, this represents a -69.6% variance from our estimated fair value.
The valuation range spans from ₹806.83 to ₹2091.71, indicating ₹806.83 - ₹2091.71.
Is ACUTAAS undervalued or overvalued?
Based on our multi-method analysis, Acutaas Chemicals (ACUTAAS) appears to be trading above calculated value by approximately 69.6%.
ACUTAAS Financial Health — Key Ratios vs Industry Benchmarks
Acutaas Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 20.98 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 32.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 42.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.90x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ACUTAAS Cash Flow Quality — Operating & Free Cash Flow
Acutaas Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹118 Cr | ₹6 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹125 Cr | ₹-58 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹66 Cr | ₹50 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-12 Cr | ₹-73 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹28 Cr | ₹-23 Cr | Positive Operating Cash Flow | 6/10 |